Visalytics
Visalytics
approved EB-2 (NIW)

Senior Data Scientist

Computational And Mathematical Engineering · India · 2025-08-05

Processing Time
46 days
Decision Date
2025-08-05
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to design and implement computational frameworks that extract epigenetic and transcriptomic patterns from single-cell immune datasets to reveal disease-associated signatures. This work involves optimizing foundation-model tokenization for immunological disease classification and developing data-driven methods to link genetic risk factors with severe infection outcomes. The endeavor aims to improve the explainability of clinical decision-support tools and enhance precision medicine.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses urgent national needs in disease surveillance and precision medicine, potentially reducing misdiagnosis rates which account for 16% of preventable patient harm.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. and has a proven record of cross-disciplinary collaboration and translating computational tools into clinical studies at a leading U.S. research institution.

3 Balance of Factors Met

The petitioner's unique expertise in computational immunology and the critical impact of their innovations on U.S. healthcare justify a waiver of the labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 7 journal articles, 2 first-authored conference abstracts, and 29 citations, including papers in top citation percentiles. Evidence of 11 invited manuscript reviews and a Ph.D. in Computational and Mathematical Engineering demonstrated the petitioner was well-positioned. The case satisfied all three Dhanasar prongs by showing the work's impact on reducing misdiagnosis rates and its alignment with federal health priorities.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · Russia

WeGreened EB-2 (NIW) approved
Missouri 564 days 2025-10-28
The petitioner proposes to discover the underlying mechanisms driving inflammatory processes linked to diseases and aging by analyzing complex immunological multi-omics data. This work focuses on identifying novel therapeutic targets to advance cancer immunotherapy and treatments for neurodegenerative diseases.
View Case

Research Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 354 days 2025-04-03
The petitioner proposes to advance the identification of new therapeutic targets for cancer, autoimmune diseases, and chronic inflammatory conditions using high-throughput technologies like single-cell sequencing. Her work focuses on examining T cell behavior within tumor microenvironments and immune responses to vaccines and cancer treatments to develop cost-effective strategies for immune modulation.
View Case

Postdoctoral Researcher

Pharmaceuticals · Egypt

WeGreened EB-2 (NIW) approved
Tennessee 646 days 2025-11-14
The petitioner proposes to examine immune system dysfunction and its relationship to serious medical conditions to uncover novel immune-targeted treatment strategies. The work focuses on identifying immunological mechanisms that inform the development of new therapeutic strategies for autoimmune disorders, cardiovascular disease, and inflammatory conditions.
View Case

Analyst

Biotechnology · India

WeGreened EB-2 (NIW) approved
New Jersey 120 days 2026-01-21
The petitioner proposes to develop and apply specialized computational methods to interpret large-scale genomics and transcriptomics data, specifically focusing on RNA-seq interpretation, immune regulation, and stem cell analysis. This work aims to translate complex biological datasets into actionable biomarkers and therapeutic targets to guide clinical decision-making.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-08-05.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 46 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist